Rep. Kevin Hern (R-OK) Sells MRSH Stock

Oklahoma Congressman Kevin Hern sold shares of Marsh & McLennan Companies, Inc. (MRSH) valued between $1,001 and $15,000 on September 14, 2026. The shares were trading at $188.36 at the time of the sale, reflecting his position in the company. This transaction was reported on September 25, 2026, under the STOCK Act, which discloses trades made by members of Congress.

Inside Kevin Hern's Trade

Hern's sale involved a transaction in a range that reflects a modest adjustment to his holdings in Marsh & McLennan. After this sale, Hern continues to hold an undisclosed number of shares in the company.

Other Institutional Activity in Marsh & McLennan

Several institutional investors have adjusted their positions in Marsh & McLennan recently. Blackrock Inc. trimmed its stake by 2,561,681 shares, bringing its total to around 39.5 million shares, valued at approximately $7.41 billion. Vanguard Capital Management LLC added 6,293 shares, ending with about 31.5 million shares worth about $5.9 billion. State Street Corporation increased its holdings by 331,059 shares, reaching a total of 22.4 million shares valued at roughly $4.2 billion. Additionally, Capital World Investors gained 152,742 shares, resulting in a total of about 18.1 million shares worth around $3.4 billion. Wellington Management Group reduced its holdings by 396,066 shares, now holding about 16.9 million shares valued at approximately $3.18 billion.

Marsh & McLennan Companies, Inc. Stock Up 1.0%

Shares of Marsh & McLennan are currently trading at $188.36, which is near its 52-week high of $207.83. This price is also above its 50-day moving average of $185.51, suggesting that the stock has been performing well recently. The company has a market cap of about $82.4 billion and a P/E ratio of 21.09, indicating it is valued on the higher end relative to its earnings.

Recent Earnings

In its latest earnings report, Marsh & McLennan posted revenue of about $27.9 billion, reflecting a growth rate of 6.2%. The company reported an EPS of $8.19 and a net margin of 14.24%. The next earnings report is scheduled for October 15, 2026.

Insider Buying and Selling at Marsh & McLennan Companies, Inc.

Recent insider trades show several sales. Brennan Katherine J., General Counsel, sold 1,197 shares at an average price of $187.90 on September 2, 2026, valued at about $224,915. CEO John Q. Doyle sold 16,656 shares at $188.51, totaling approximately $3.14 million on the same date. Officer John Jude Jones sold 6,500 shares at an average price of $191.96 on August 6, 2026, valued at about $1.25 million. Lastly, Chief Technology Officer Paul Beswick sold 713 shares at $198.00 on July 29, 2026, worth around $141,174.

Analysts Set New Price Targets

Analysts have been maintaining their ratings on Marsh & McLennan. On October 6, 2026, Morgan Stanley maintained its rating of Equal-Weight with a price target of $180.00, down from $200.00. UBS also maintained a Buy rating with a target of $222.00, a slight increase from $216.00. Wells Fargo maintained its Equal-Weight rating with targets of $197.00 and $183.00 in separate reports on October 12 and 16, 2026. The consensus recommendation is to hold, with a mean target price of approximately $207.10 based on 21 analyst opinions.

About Marsh & McLennan Companies, Inc.

Marsh & McLennan is a professional services firm based in New York, specializing in risk management and insurance solutions. The company serves clients across various industries, providing services that help manage risks and streamline insurance processes. This trade by Congressman Hern adds to his previous transactions in other companies and reflects ongoing adjustments in his investment portfolio.

Bottom Line

Looking ahead, investors will be watching for more insider activity and the upcoming earnings report on October 15, 2026. Hern's recent trades highlight his engagement with stock market activities, and this sale was reported under the STOCK Act, which requires transparency in Congressional trading activities.